Shawn Leland
Director/Miembro de la Junta en Fore Biotherapeutics, Inc. .
Cargos activos de Shawn Leland
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Director/Miembro de la Junta | 01/09/2023 | - |
Director Ejecutivo | 01/09/2023 | 29/02/2024 |
Historial de carrera de Shawn Leland
Antiguos cargos conocidos de Shawn Leland.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ELEVATION ONCOLOGY, INC. | Director/Miembro de la Junta | 01/01/2019 | 05/01/2023 |
Director Ejecutivo | 18/11/2020 | 05/01/2023 | |
Fundador | 01/01/2019 | 05/01/2023 | |
Corporate Officer/Principal | 01/01/2019 | 18/11/2020 | |
Presidente | 18/11/2020 | 05/01/2023 | |
VERASTEM, INC. | Corporate Officer/Principal | 01/09/2017 | 01/08/2019 |
ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2013 | 01/09/2017 |
Formación de Shawn Leland.
Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ELEVATION ONCOLOGY, INC. | Health Technology |
VERASTEM, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Shawn Leland
- Experiencia